146 related articles for article (PubMed ID: 29317944)
1. Is the Glasgow Prognostic Score Applicable to Both Early- and Advanced-Stage Gastric Cancers?
Wakahara T; Ueno N; Maeda T; Kanemitsu K; Yoshikawa T; Tsuchida S; Toyokawa A
Gastroenterology Res; 2017 Dec; 10(6):359-365. PubMed ID: 29317944
[TBL] [Abstract][Full Text] [Related]
2. Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score.
Hirahara N; Matsubara T; Kaji S; Kawabata Y; Hyakudomi R; Yamamoto T; Uchida Y; Ishitobi K; Takai K; Tajima Y
Oncotarget; 2020 Nov; 11(45):4169-4177. PubMed ID: 33227100
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer.
Lin MS; Huang JX; Yu H
Int J Clin Exp Med; 2015; 8(10):19138-43. PubMed ID: 26770545
[TBL] [Abstract][Full Text] [Related]
4. Glasgow Prognostic Score is superior to ECOG PS as a prognostic factor in patients with gastric cancer with peritoneal seeding.
Yuan SQ; Nie RC; Chen YM; Qiu HB; Li XP; Chen XJ; Xu LP; Yang LF; Sun XW; Li YF; Zhou ZW; Chen S; Chen YB
Oncol Lett; 2018 Apr; 15(4):4193-4200. PubMed ID: 29541185
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer.
Kochi M; Fujii M; Kanamori N; Kaiga T; Kawakami T; Aizaki K; Kasahara M; Mochizuki F; Kasakura Y; Yamagata M
Gastric Cancer; 2000 Dec; 3(4):177-186. PubMed ID: 11984734
[TBL] [Abstract][Full Text] [Related]
6. Improvement of high-sensitivity inflammation-based Glasgow prognostic score by gastrectomy is a favorable prognostic factor in patients with gastric cancer.
Takeno S; Hashimoto T; Shibata R; Maki K; Shiwaku H; Yamana I; Yamashita R; Yamashita Y
Anticancer Res; 2014 Oct; 34(10):5695-702. PubMed ID: 25275076
[TBL] [Abstract][Full Text] [Related]
7. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer.
Jiang X; Hiki N; Nunobe S; Kumagai K; Kubota T; Aikou S; Sano T; Yamaguchi T
Br J Cancer; 2012 Jul; 107(2):275-9. PubMed ID: 22713657
[TBL] [Abstract][Full Text] [Related]
8. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
[TBL] [Abstract][Full Text] [Related]
9. Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis.
Hirahara N; Tajima Y; Fujii Y; Kaji S; Yamamoto T; Hyakudomi R; Taniura T; Kawabata Y
BMC Cancer; 2018 Mar; 18(1):285. PubMed ID: 29534689
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of an inflammation-based prognostic system for gastric cancer patients with a preoperative normal serum level of carcinoembryonic antigen.
Ishizuka M; Oyama Y; Abe A; Tago K; Tanaka G; Kubota K
Anticancer Res; 2014 Dec; 34(12):7219-26. PubMed ID: 25503152
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer.
Suenaga Y; Kanda M; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
World J Gastrointest Oncol; 2019 Jan; 11(1):17-27. PubMed ID: 30984347
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
13. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
Jiang AG; Chen HL; Lu HY
BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer.
Hirashima K; Watanabe M; Shigaki H; Imamura Y; Ida S; Iwatsuki M; Ishimoto T; Iwagami S; Baba Y; Baba H
J Gastroenterol; 2014 Jun; 49(6):1040-6. PubMed ID: 23821018
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
[TBL] [Abstract][Full Text] [Related]
16. The Glasgow prognostic score is valuable for colorectal cancer with both synchronous and metachronous unresectable liver metastases.
Furukawa K; Shiba H; Haruki K; Fujiwara Y; Iida T; Mitsuyama Y; Ogawa M; Ishida Y; Misawa T; Yanaga K
Oncol Lett; 2012 Aug; 4(2):324-328. PubMed ID: 22844378
[TBL] [Abstract][Full Text] [Related]
17. Glasgow prognostic score predicts therapeutic outcome after pancreaticoduodenectomy for carcinoma of the ampulla of vater.
Shiba H; Misawa T; Fujiwara Y; Futagawa Y; Furukawa K; Haruki K; Iwase R; Wakiyama S; Ishida Y; Yanaga K
Anticancer Res; 2013 Jun; 33(6):2715-21. PubMed ID: 23749931
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of Glasgow prognostic score in patients with colorectal cancer undergoing laparoscopic radical resection].
Cao X; Yu T; Zhao G; Xiao G
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1133-1138. PubMed ID: 27781250
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer.
Kimura J; Kunisaki C; Makino H; Oshima T; Ota M; Oba M; Takagawa R; Kosaka T; Ono HA; Akiyama H; Endo I
Dis Esophagus; 2016 Nov; 29(8):1071-1080. PubMed ID: 26471766
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer.
Toiyama Y; Miki C; Inoue Y; Tanaka K; Mohri Y; Kusunoki M
Exp Ther Med; 2011 Jan; 2(1):95-101. PubMed ID: 22977476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
